Report of Foreign Issuer (6-k)
April 13 2017 - 5:21PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of April, 2017
Commission File Number: 001-15152
SYNGENTA AG
(Translation of registrant’s name into
English)
Schwarzwaldallee 215
4058 Basel
Switzerland
(Address of
principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
|
Disclosure:
|
“
ChemChina announces end of public tender offers for Syngenta on May 4, 2017”
|
Herewith we furnish a press release
related to Syngenta AG. The full text of the press release is the following:
# # #
Syngenta International AG
|
Media contacts:
|
Analyst/Investor contacts:
|
|
|
|
|
|
|
Media Office
|
Leandro Conti
|
Jennifer Gough
|
CH-4002 Basel
|
Switzerland
|
+41 61 323 2323
|
Switzerland
|
+41 61 323 5059
|
Switzerland
|
|
|
USA
|
+1 202 737 6521
|
Tel:
|
+41 61 323 2323
|
|
|
|
|
Fax:
|
+41 61 323 2424
|
Paul Minehart
|
|
|
|
|
USA
|
+1 202 737 8913
|
|
|
www.syngenta.com
|
|
|
|
|
Basel, Switzerland,
April 13, 2017
ChemChina announces end of
public tender offers for Syngenta on May 4, 2017
ChemChina
announced today that the tender offers to purchase all publicly held Syngenta shares and ADSs will end on 4 May, 2017.
In accordance
with the framework for extensions set by the Swiss Takeover Board, ChemChina made use of the last possibility to extend the Swiss
Offer provided by that framework. Accordingly, the Swiss Offer will end on May 4, 2017 at 4:00 p.m. CEST, and the U.S. Offer will
end on May 4, 2017 at 10:00 am, New York City time.
Accordingly,
shareholders willing to tender their shares or ADSs into the offers and thereby contribute to the satisfaction of the minimum
acceptance rate condition are asked to tender their shares or ADSs by 4 May, 2017 or an earlier deadline set by their custodian
bank.
The Board
of Directors of Syngenta has unanimously recommended the offer to shareholders. The ChemChina-Syngenta transaction respects the
interests of all stakeholders and will ensure continued choice and ongoing innovation for growers around the world.
About
Syngenta
Syngenta
is a leading agriculture company helping to improve global food security by enabling millions of farmers to make better use of
available resources. Through world class science and innovative crop solutions, our 28,000 people in over 90 countries are working
to transform how crops are grown. We are committed to rescuing land from degradation, enhancing biodiversity and revitalizing
rural communities. To learn more visit
www.syngenta.com
and
www.goodgrowthplan.com
.
Follow us on Twitter
®
at
www.twitter.com/Syngenta
.
Disclaimer
This press release is
not an offer to purchase or a solicitation of an offer to sell any securities.
Additional information
and where to find it
This press
release is for informational purposes only and does not constitute an offer to purchase or a solicitation of an offer to sell company
securities. The solicitation and offer to buy company securities is only made pursuant to the Swiss offer prospectus and the offer
to purchase and other documents relating to the U.S. offer that have been filed with the US Securities and Exchange Commission
(“SEC”). At the time the US Public Tender Offer was commenced, ChemChina and a designated direct or indirect subsidiary
filed a tender offer statement on Schedule TO with the SEC and thereafter, the company filed a solicitation/recommendation statement
on Schedule 14d-9 with respect to the offer. Investors and security holders are urged to read these materials carefully since they
contain important information, including the terms and conditions of the offer. Investors and security holders may obtain a free
copy of these materials and other documents filed by ChemChina and the company with the SEC at the website maintained by the SEC
at
www.sec.gov
. Investors and security holders may
also obtain free copies of the solicitation/recommendation statement and other documents filed with the SEC by the company at
www.syngenta.com
.
Cautionary
statement regarding forward-looking statements
Some
of the statements contained in this press release are forward-looking statements, including statements regarding the expected
consummation of the acquisition, which involves a number of risks and uncertainties, including the satisfaction of closing conditions
for the acquisition, such as regulatory approval for the transaction and the tender of at least 67% of the outstanding shares
of the company, the possibility that the transaction will not be completed and other risks and uncertainties discussed in the
company’s public filings with the SEC, including the “risk factors” section of the company’s form 20-F
filed on February 16, 2017 as well as the tender offer documents filed by the offeror and the solicitation/recommendation statement
filed by the company. These statements are based on current expectations, assumptions, estimates and projections, and involve
known and unknown risks, uncertainties and other factors that may cause results, levels of activity, performance or achievements
to be materially different from any forward-looking statements. These statements are generally identified by words or phrases
such as “believe”, “anticipate”, “expect”, “intend”, “plan”, “will”,
“may”, “should”, “estimate”, “predict”, “potential”, “continue”
or the negative of such terms or other similar expressions. If underlying assumptions prove inaccurate or unknown risks or uncertainties
materialize, actual results and the timing of events may differ materially from the results and/or timing discussed in the forward-looking
statements, and you should not place undue reliance on these statements. The offeror, ChemChina and the company disclaim any intent
or obligation to update any forward-looking statements as a result of developments occurring after the period covered by this
press release or otherwise.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
|
|
SYNGENTA AG
|
|
|
|
|
|
|
|
|
|
Date:
|
April 13, 2017
|
|
By:
|
/s/
Tobias Meili
|
|
|
|
|
Name:
|
Dr.
Tobias Meili
|
|
|
|
|
Title:
|
Head Corporate Legal Affairs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/
Brigitte Benz
|
|
|
|
|
Name:
|
Brigitte
Benz
|
|
|
|
|
Title:
|
Head Shareholder Services & Group Administration
|
|
|
|
|
|
|
Syngenta (NYSE:SYT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Syngenta (NYSE:SYT)
Historical Stock Chart
From Jul 2023 to Jul 2024